|By Business Wire||
|April 21, 2014 04:52 PM EDT||
VuCOMP, Inc. announced today that it has been issued two patents for technology related to its M-Vu® CAD System for mammography. VuCOMP has also filed seven more patents, including two for healthcare applications other than breast cancer detection.
The number of patent applications reflects VuCOMP’s dedication to medical imaging innovation, continual product improvement, and aggressive protection of its unique technologies. The content of the applications includes advances related to its core technology—computer-aided detection and automated breast density assessment for mammography—as well as other advancements for future applications such as Lung Segmentation and Bone Suppression Techniques for Chest X-Rays.
“VuCOMP’s dedication to continual discovery and product innovation for our customers is at the forefront of our mission,” said company President Jim Pike. “Our pipeline of patent applications is a testament to this commitment. We believe our customers and their patients benefit directly from improved developments in medical imaging technology.”
VuCOMP’s patent announcement follows the release of its updated M-Vu Breast Density assessment system, Version 2.0, an enhancement that was made immediately available to existing customers.
About VuCOMP, Inc.
VuCOMP, Inc. leads the way in setting a new standard for mammography CAD and automated breast density measurement. The company is dedicated exclusively to developing advanced cancer detecting technologies. VuCOMP’s engineering team has worked together since 1986, pioneering some of the world’s most advanced computer vision systems. For more information, please visit www.vucomp.com.